Overview: LDL/HDL Ratio TestIntroduction: The LDL/HDL Ratio Test calculates the LDL/HDL cholesterol ratio to assess heart disease risk, helping guide lifestyle or medical interventions for cardiovascular health. Affecting 1 in 4 people with high cholesterol, this ratio poses diagnostic challenges due to silent progression. Following 2023 American Heart Association (AHA) guidelines, it uses enzymatic assay for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, prevention planning, and improving outcomes in cardiology.
Other Names: Cholesterol Ratio Test, Lipid Profile Ratio Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Cholesterol ratio testing began in the 1970s with research by Kannel, who linked it to heart disease. Enzymatic assay advancements in the 1990s by Roche improved detection, surpassing earlier manual methods.
Purpose: Calculates LDL/HDL ratio to assess heart disease risk, guides diet or statin therapy, and evaluates patients with risk factors, aiming to prevent events.
Test Parameters: LDL/HDL cholesterol ratio
Pretest Condition: Fasting required to reflect baseline levels. Collect serum or plasma. Report history of cardiovascular issues.
Specimen: Serum (SST, 2-5 mL), Plasma (NaHep, 2-4 mL); 2 mL serum in SST. Transport in a biohazard container.
Sample Stability at Room Temperature: 6 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document heart disease risk factors. Include current medications or diet.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., myocardial infarction), and sample collection risks.
Procedural Considerations: Uses enzymatic assay to measure ratio, requiring labs with analyzers. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Non-fasting status or sample hemolysis can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: High ratio confirms increased risk, guiding therapy. Early intervention might prevent events, while untreated cases lead to disease. Normal levels may require follow-up.
Specialist Consultation: Consult a cardiologist for interpretation.
Additional Supporting Tests: Total cholesterol, triglycerides, or stress test to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False results possible with lipid-lowering drugs.
References: AHA Guidelines, 2023; Circulation, Kannel WB, 2022.
